Literature DB >> 18163960

Construction and identification of a human liver specific microRNA eukaryotic expression vector.

Shanshan Chen1, Ming Ni, Bing Yu, Tingting Lv, Mengji Lu, Feili Gong.   

Abstract

MiR-122 is one of the non-coding RNAs which showed its effects on the lipo-metablism, virus infection and HCC forming through regulation of liver gene expression. Its eukaryotic expression vector was constructed by using pSuper which was widely applied in the siRNA expression. The precursor of human miR-122 gene was amplified by polymerase chain reaction (PCR) from the human genomic DNA. The positive clones were screened by PCR and restriction enzyme digestion. The new expression vector of miR-122 was named pHsa-m122. PHsa-m122 and its controls were transfected to HepG2 cells. The miR-122 expression activity was evaluated by GFP122i sensor reporter plasmid through fluorescence detection and Western blot. It was shown that the fluorescence intensity of GFP122si and pHsa-m122 co-transfection group was weaker than that of the controls, so the functional activity of expressed miR-122 was detected. When HepG2 cells were co-transfected with HBV1.3 and pHsa-m122 plasmids, the results showed miR-122 may down-regulate the gene expression of HBV. The human liver specific microRNA eukaryotic expression vector of miR-122 was constructed successfully, which may facilitate further study of its function in the development of liver virus infection diseases and HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163960

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  5 in total

Review 1.  MiR-122 in hepatic function and liver diseases.

Authors:  Jun Hu; Yaxing Xu; Junli Hao; Saifeng Wang; Changfei Li; Songdong Meng
Journal:  Protein Cell       Date:  2012-05-18       Impact factor: 14.870

2.  MicroRNA let-7: an emerging next-generation cancer therapeutic.

Authors:  D Barh; R Malhotra; B Ravi; P Sindhurani
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

3.  Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection.

Authors:  Qingqing Fang; Wei Chen; Yourong Jian; Yu Li; Wei Lian; Hongyu Wan; Shiyao Chen; Feng Li; Ying Chen
Journal:  J Healthc Eng       Date:  2022-02-24       Impact factor: 2.682

4.  MicroRNA: An emerging therapeutic target and intervention tool.

Authors:  Zhen Liu; Alhousseynou Sall; Decheng Yang
Journal:  Int J Mol Sci       Date:  2008-06-13       Impact factor: 6.208

Review 5.  Gene therapy in animal models of autosomal dominant retinitis pigmentosa.

Authors:  Brian Rossmiller; Haoyu Mao; Alfred S Lewin
Journal:  Mol Vis       Date:  2012-10-06       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.